Propanc Biopharma, Inc.
PPCB· Nasdaq
PPCBPropanc Biopharma, Inc.
Filed May 15, 2020 · 10-Q · 45 days after period end · 0001493152-20-009146
| Metric | Q3 2020 | Q3 2019 | Q3 2018 | Q3 2017 |
|---|---|---|---|---|
| Net Income | -$2.59M | -$581.86K | -$1.49M | -$1.37M |
| EPS Diluted | -$348.75 | -$0.89 | -$0.06 | -$0.38 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Propanc Biopharma, Inc. · CIK 1517681 · Engraved from SEC EDGAR
ended Mar 31, 2020 · filed May 15, 2020 · 45 d after period end
